ATE125869T1 - Wachstumshormonfusionsproteine. - Google Patents

Wachstumshormonfusionsproteine.

Info

Publication number
ATE125869T1
ATE125869T1 AT90908176T AT90908176T ATE125869T1 AT E125869 T1 ATE125869 T1 AT E125869T1 AT 90908176 T AT90908176 T AT 90908176T AT 90908176 T AT90908176 T AT 90908176T AT E125869 T1 ATE125869 T1 AT E125869T1
Authority
AT
Austria
Prior art keywords
pct
growth hormone
growth
igf
polypeptide
Prior art date
Application number
AT90908176T
Other languages
English (en)
Inventor
Julian Richard Este Wells
Robert Michael King
Geoffrey Leonard Francis
Original Assignee
Gropep Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gropep Pty Ltd filed Critical Gropep Pty Ltd
Application granted granted Critical
Publication of ATE125869T1 publication Critical patent/ATE125869T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT90908176T 1989-06-09 1990-05-22 Wachstumshormonfusionsproteine. ATE125869T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPJ467289 1989-06-09

Publications (1)

Publication Number Publication Date
ATE125869T1 true ATE125869T1 (de) 1995-08-15

Family

ID=3773983

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90908176T ATE125869T1 (de) 1989-06-09 1990-05-22 Wachstumshormonfusionsproteine.

Country Status (6)

Country Link
US (1) US5330971A (de)
EP (1) EP0429586B1 (de)
AT (1) ATE125869T1 (de)
CA (1) CA2033176C (de)
DE (1) DE69021335T2 (de)
WO (1) WO1990015142A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977307A (en) * 1989-09-07 1999-11-02 Alkermes, Inc. Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
DE69129267T2 (de) * 1990-02-13 1998-09-10 Gropep Pty Ltd Methode zur behandlung intestinaler krankheiten
US5210017A (en) * 1990-11-19 1993-05-11 Genentech, Inc. Ligand-mediated immunofunctional hormone binding protein assay method
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
ATE314479T1 (de) * 1992-05-18 2006-01-15 Genentech Inc Aktivierung von rezeptoren fähig zur oligomerisierung durch verwendung von fusionierten rezeptor liganden
US5763584A (en) * 1992-05-18 1998-06-09 Genentech, Inc. Receptor activation with hepatocyte growth factor agonists
NZ243071A (en) * 1992-06-08 1994-09-27 Kabi Pharmacia Ab Igf-2 (or analogue) compositions for pharmaceutical uses
JPH06510065A (ja) * 1992-06-08 1994-11-10 カイロン　コーポレーション 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法
US5444045A (en) * 1992-09-17 1995-08-22 Gropep, Pty. Ltd. Method of administering IGF-1, IGF-2, and analogs thereof to birds
AU1178395A (en) * 1993-11-12 1995-05-29 North Shore University Hospital Research Corporation Method of treating muscular dystrophy
GB9526733D0 (en) * 1995-12-30 1996-02-28 Delta Biotechnology Ltd Fusion proteins
EP1950223A3 (de) * 1998-03-09 2009-05-13 Zealand Pharma A/S Pharmakologisch aktive Peptidkonjugate mit verringerter enzymatischer Hydrolysetendenz
AUPP298498A0 (en) * 1998-04-17 1998-05-07 Gropep Pty Ltd Matrix binding factor
WO2000034312A1 (en) * 1998-12-10 2000-06-15 Samyang Genex Corporation Method of separating basic peptide or basic protein
AUPQ387599A0 (en) * 1999-11-05 1999-12-02 Metabolic Pharmaceuticals Limited Product and method for control of obesity
CN1296974A (zh) * 1999-11-23 2001-05-30 上海博容基因开发有限公司 一种新的多肽——人组蛋白h2a.21和编码这种多肽的多核苷酸
EP1274720A4 (de) * 2000-04-12 2004-08-18 Human Genome Sciences Inc Albumin enthaltende fusionsproteine
US6946134B1 (en) 2000-04-12 2005-09-20 Human Genome Sciences, Inc. Albumin fusion proteins
JP4173732B2 (ja) * 2000-11-28 2008-10-29 プレマキュア・アクチボラグ 未熟児合併症のリスクの決定および治療
US20060084794A1 (en) * 2001-04-12 2006-04-20 Human Genome Sciences, Inc. Albumin fusion proteins
US7507413B2 (en) 2001-04-12 2009-03-24 Human Genome Sciences, Inc. Albumin fusion proteins
US20050054051A1 (en) * 2001-04-12 2005-03-10 Human Genome Sciences, Inc. Albumin fusion proteins
US20050244931A1 (en) * 2001-04-12 2005-11-03 Human Genome Sciences, Inc. Albumin fusion proteins
WO2003030821A2 (en) * 2001-10-05 2003-04-17 Human Genome Sciences, Inc. Albumin fusion proteins
CA2841097A1 (en) 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin and g-csf fusion proteins
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
US7355018B2 (en) 2003-09-30 2008-04-08 Regeneron Pharmaceuticals, Inc. Modified IGF1 polypeptides with increased stability and potency
WO2006074390A2 (en) 2005-01-07 2006-07-13 Regeneron Pharmaceuticals, Inc. Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides
US20080103457A1 (en) * 2005-01-11 2008-05-01 Heart Failure Technologies, Inc. University Enterprise Laboratories (Uel) Method and System for Treating Heart Failure
WO2007068053A1 (en) * 2005-12-15 2007-06-21 Gropep Limited Recombinant protein production
WO2008035230A2 (en) * 2006-09-18 2008-03-27 Novozymes Gropep Limited Liquid compositions comprising substantially purified igf at or below ph 5.0
PE20161326A1 (es) 2014-04-10 2016-12-11 Bayer Healthcare Llc Formulacion en polvo de medio de compuesto y metodo de preparacion de medio liquido para cultivo celular
HUE057135T2 (hu) 2015-09-01 2022-04-28 Ncardia B V In vitro módszer egy humán pluripotens õssejtpopuláció kardiomiocita sejtpopulációvá történõ differenciálására

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK108685A (da) * 1984-03-19 1985-09-20 Fujisawa Pharmaceutical Co Vaekstfaktor i
US5028531A (en) * 1984-03-19 1991-07-02 Fujisawa Pharmaceutical Company, Ltd. IGF-I fusion proteins; protection of IGF-I from degradation by host cell; and processes for the production thereof
EP0235205B1 (de) * 1985-08-22 1992-10-28 Gropep Pty. Ltd. Peptidanalogedes insulinähnlichen wachstumsfaktors-1 bei säugetieren
AU613876B2 (en) * 1986-10-01 1991-08-15 Merck & Co., Inc. Synthetic genes encoding proteins from plasmid containing eucaryotic secretory signal peptides and process for secreting encoded proteins
FR2619719B1 (fr) * 1987-09-01 1991-05-10 Sanofi Sa Procede d'obtention d'interleukine-2 a partir de cellules eucaryotes, vecteurs necessaires a sa mise en oeuvre et lignees cellulaires hautement productrices
JPH01144981A (ja) * 1987-12-02 1989-06-07 Wakunaga Pharmaceut Co Ltd 蛋白質の製造
JP2507106B2 (ja) * 1987-12-24 1996-06-12 グロペップ プロプライエタリー リミテッド インスリン様成長因子１（ｉｇｆ―１）または因子２（ｉｇｆ―２）の類縁ペプチド

Also Published As

Publication number Publication date
EP0429586B1 (de) 1995-08-02
EP0429586A1 (de) 1991-06-05
WO1990015142A1 (en) 1990-12-13
DE69021335T2 (de) 1996-04-11
DE69021335D1 (de) 1995-09-07
US5330971A (en) 1994-07-19
CA2033176A1 (en) 1990-12-10
EP0429586A4 (en) 1992-07-08
CA2033176C (en) 1999-12-14

Similar Documents

Publication Publication Date Title
ATE125869T1 (de) Wachstumshormonfusionsproteine.
DK488386A (da) Human-metallothionein-ii promotor i pattedyrekspressionssystemer
DE60023906D1 (de) Superaktive, wachstumshormone freisetzende hormonanaloge vom schwein
ATE84707T1 (de) Implantate mit verzoegerter abgabe fuer die anwendung von rekombinanten wachstumshormonen.
DK80886D0 (da) Biologisk aktive proteiner samt fremgangsmaade til deres fremstillingog anvendelse
ATE131532T1 (de) Expression von biologisch-aktiven pdgf-analogen in eukaryotischen zellen
AU637139B2 (en) Gm-csf protein, its derivatives, the preparation of proteins of this type, and their use
KR900002795A (ko) 하이브리드 단백질c 작제물 및 그들의 제조방법
ATE246247T1 (de) Varianten des humanen rekombinanten interferon- gamma (rhu-ifn-gamma) mit erhöhter thermischer stabilität
IL102346A0 (en) Cysteine depleted il-6 muteins
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
SE9403055D0 (sv) A new human peptide antibiotic (FALL-39) and its use
JPS6420086A (en) Polypeptide and production thereof
MXPA01011158A (es) Factor de crecimiento homologo zvegf4.
FI963755A (fi) Glutamaatti-dekarboksylaasi-aktiivisuutta (GAD-aktiivisuutta) koodaavat yhdistelmä-DNA-tekniset virukset
AU637589B2 (en) Ancrod proteins, their production and use
DK411389A (da) Fremgangsmaade og middel til forbedring af koedkvalitet
高亚胜 et al. A PRIMARY OBSERVATION OF TPA EFFECT ON SSV-NIH3T3 CELLS IN SERUM-FREE MEDIUM
IT1262997B (it) Composto proteico e sequenze nucleotidiche codificanti per esso.
AR242636A1 (es) Gen con codificacion para actividad de factor estimulante de colonias de granulocitos humanos.
SG165136A1 (en) Recombinant molecules and uses therefor
NO941982L (no) Fremstilling av proteiner ved anvendelse av 7B2 protein
TH21046B (th) ฮอร์โมนเทียมเพื่อการเจริญเติบโตของหมู

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties